Author:
Seyyedi Mahdiyeh Sadat,Monfared Mohammad,Mirzaei Esmaeil,Azarpira Negar
Abstract
AbstractThe main barriers to cells or organ transplantation such as pancreatic β-cells are the need for lifelong immune suppression and the shortage of donors. It may be overcome via cell encapsulation and transplantation techniques. Hydrogels provide a suitable ECM-like microenvironment for cells to adhere, survive, and function, while weakly performing as an immune barrier. In this study, we aimed to macro-encapsulate islet cells in a dual encapsulation device with collagen hydrogel and PCL nanofiber to provide an immune-isolated environment for cells to function more efficiently, where immune cells are not allowed to enter but oxygen, insulin, and nutrients can pass through. PCL thin mats with the pores diameter of 500 nm were synthesized by electrospinning and characterized by scanning electron microscope, porosity measurement, tensile strength test, and contact angle measurement. Collagen hydrogel was fabricated by extracting collagen fibers from rat tail tendons and solving them in acetic acid. β-cells (CRI-D2 cell line) encapsulated after neutralizing collagen solution (pH ≈ 7.4). Cell-collagen gel complex was poured into the nanofibrous mat packets to fabricate the whole device. Histology evaluation, cell viability, and cell function tests were done in 10 days. Live/dead assay of Cri-D2 cells encapsulated within the device showed that cells have diffuse distribution at the core of the hydrogel and the device. Also, cluster formation was seen and shows these cells can live in groups. To identify cells’ function within the device in these 10 days samples’ supernatant insulin level was measured by chemiluminescent immunoassay. It just showed a positive result for existing insulin within the medium. Based on our results, this device presents adequate features to be a good immune-isolation device for cell transplanting.
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma, https://www.fda.gov/news-events/press-announcements/fda-approves-car-t-cell-therapy-treat-adults-certain-types-large-b-cell-lymphoma (2017).
2. Colombo, F., Sampogna, G., Cocozza, G., Guraya, S. Y. & Forgione, A. Regenerative medicine: Clinical applications and future perspectives. J. Microsc. Ultrastruct. 5, 1–8 (2017).
3. Mao, A. S. & Mooney, D. J. Regenerative medicine: Current therapies and future directions. Proc. Natl. Acad. Sci. 112, 14452–14459 (2015).
4. Sánchez, A., Schimmang, T. & García-Sancho, J. in Stem Cell Transplantation 89–102 (Springer, 2012).
5. Díaz, M. L. Regenerative medicine: Could Parkinson’s be the first neurodegenerative disease to be cured?. Future Sci. OA 5, FSO418 (2019).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献